Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial
Nephrology Dialysis Transplantation, 05/24/2012Locatelli F et al.
In comparison with low–flux haemodialysis, convective treatments did not significantly improve haemoglobin levels or erythropoiesis–stimulating agent (ESA) resistance. The main sources of variability were participating centres, ESA dose and the underlying disease.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.